Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcela Horvitz-Lennon

Showing results (31-40 of 68) with videos related to

Pageof 7
Sort By:
Psychiatric Services (Washington, D.C.)|December 17, 2013
Changes in physician antipsychotic prescribing preferences, 2002-2007Julie Donohue, A James O'Malley, Marcela Horvitz-Lennon, et al.
Early Intervention in Psychiatry|December 15, 2018
Simulated long-term outcomes of early use of long-acting injectable antipsychotics in early schizophreniaMarcela Horvitz-Lennon, Zachary Predmore, Patrick Orr, et al.
Bjpsych Open|August 8, 2024
Revisiting diabetes risk of olanzapine versus aripiprazole in serious mental illness careDenis Agniel, Sharon-Lise T Normand, John W Newcomer, et al.
Administration and Policy in Mental Health|May 19, 2021
Significance and Factors Associated with Antipsychotic Polypharmacy Utilization Among Publicly Insured US AdultsMarcela Horvitz-Lennon, Rita Volya, Katya Zelevinsky, et al.
Psychiatric Services (Washington, D.C.)|June 2, 2021
Factors Associated With Off-Label Utilization of Second-Generation Antipsychotics Among Publicly Insured AdultsMarcela Horvitz-Lennon, Rita Volya, Simon Hollands, et al.
Administration and Policy in Mental Health|July 25, 2020
Providing Health Physicals and/or Health Monitoring Services in Mental Health Clinics: Impact on Laboratory Screening and Monitoring for High Risk PopulationsJoshua Breslau, Emily Leckman-Westin, Bing Han, et al.
Psychiatric Services (Washington, D.C.)|January 3, 2013
How quickly do physicians adopt new drugs? The case of second-generation antipsychoticsHaiden A Huskamp, A James O'Malley, Marcela Horvitz-Lennon, et al.
The Journal of Mental Health Policy and Economics|July 26, 2016
Regional Variation in Physician Adoption of Antipsychotics: Impact on US Medicare ExpendituresJulie M Donohue, Sharon-Lise T Normand, Marcela Horvitz-Lennon, et al.
Health Services Research|March 18, 2014
Disparities in quality of care among publicly insured adults with schizophrenia in four large U.S. states, 2002-2008Marcela Horvitz-Lennon, Rita Volya, Julie M Donohue, et al.
JAMA Network Open|January 17, 2025
Race and Ethnicity and Diffusion of Telemedicine in Medicaid for Schizophrenia Care After Onset of the COVID-19 PandemicSharon-Lise Normand, Emily Leckman-Westin, Molly Finnerty, et al.
Pageof 7

Showing results (31-40 of 68) with videos related to

Sort By:
Pageof 7
Psychiatric Services (Washington, D.C.)|December 17, 2013
Changes in physician antipsychotic prescribing preferences, 2002-2007Julie Donohue, A James O'Malley, Marcela Horvitz-Lennon, et al.
Early Intervention in Psychiatry|December 15, 2018
Simulated long-term outcomes of early use of long-acting injectable antipsychotics in early schizophreniaMarcela Horvitz-Lennon, Zachary Predmore, Patrick Orr, et al.
Bjpsych Open|August 8, 2024
Revisiting diabetes risk of olanzapine versus aripiprazole in serious mental illness careDenis Agniel, Sharon-Lise T Normand, John W Newcomer, et al.
Administration and Policy in Mental Health|May 19, 2021
Significance and Factors Associated with Antipsychotic Polypharmacy Utilization Among Publicly Insured US AdultsMarcela Horvitz-Lennon, Rita Volya, Katya Zelevinsky, et al.
Psychiatric Services (Washington, D.C.)|June 2, 2021
Factors Associated With Off-Label Utilization of Second-Generation Antipsychotics Among Publicly Insured AdultsMarcela Horvitz-Lennon, Rita Volya, Simon Hollands, et al.
Administration and Policy in Mental Health|July 25, 2020
Providing Health Physicals and/or Health Monitoring Services in Mental Health Clinics: Impact on Laboratory Screening and Monitoring for High Risk PopulationsJoshua Breslau, Emily Leckman-Westin, Bing Han, et al.
Psychiatric Services (Washington, D.C.)|January 3, 2013
How quickly do physicians adopt new drugs? The case of second-generation antipsychoticsHaiden A Huskamp, A James O'Malley, Marcela Horvitz-Lennon, et al.
The Journal of Mental Health Policy and Economics|July 26, 2016
Regional Variation in Physician Adoption of Antipsychotics: Impact on US Medicare ExpendituresJulie M Donohue, Sharon-Lise T Normand, Marcela Horvitz-Lennon, et al.
Health Services Research|March 18, 2014
Disparities in quality of care among publicly insured adults with schizophrenia in four large U.S. states, 2002-2008Marcela Horvitz-Lennon, Rita Volya, Julie M Donohue, et al.
JAMA Network Open|January 17, 2025
Race and Ethnicity and Diffusion of Telemedicine in Medicaid for Schizophrenia Care After Onset of the COVID-19 PandemicSharon-Lise Normand, Emily Leckman-Westin, Molly Finnerty, et al.
Pageof 7